Prediction of antimicrobial resistance in clinical Campylobacter jejuni isolates from whole-genome sequencing data
Open Access
- 24 September 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 40 (4) , 673-682
Abstract
Campylobacter jejuni is recognised as the leading cause of bacterial gastroenteritis in industrialised countries. Although the majority of Campylobacter infections are self-limiting, antimicrobial treatment is necessary in severe cases. Therefore, the development of antimicrobial resistance (AMR) in Campylobacter is a growing public health challenge and surveillance of AMR is important for bacterial disease control. The aim of this study was to predict antimicrobial resistance in C. jejuni from whole-genome sequencing data. A total of 516 clinical C. jejuni isolates collected between 2014 and 2017 were subjected to WGS. Resistance phenotypes were determined by standard broth dilution, categorising isolates as either susceptible or resistant based on epidemiological cutoffs for six antimicrobials: ciprofloxacin, nalidixic acid, erythromycin, gentamicin, streptomycin, and tetracycline. Resistance genotypes were identified using an in-house database containing reference genes with known point mutations and the presence of resistance genes was determined using the ResFinder database and four bioinformatical methods (modified KMA, ABRicate, ARIBA, and ResFinder Batch Upload). We identified seven resistance genes including tet(O), tet(O/32/O), ant(6)-Ia, aph(2″)-If, blaOXA, aph(3′)-III, and cat as well as mutations in three genes: gyrA, 23S rRNA, and rpsL. There was a high correlation between phenotypic resistance and the presence of known resistance genes and/or point mutations. A correlation above 98% was seen for all antimicrobials except streptomycin with a correlation of 92%. In conclusion, we found that WGS can predict antimicrobial resistance with a high degree of accuracy and have the potential to be a powerful tool for AMR surveillance.Keywords
Funding Information
- Horizon 2020 (773830)
This publication has 52 references indexed in Scilit:
- Antimicrobial Resistance Mechanisms amongCampylobacterBioMed Research International, 2013
- Identification of acquired antimicrobial resistance genesJournal of Antimicrobial Chemotherapy, 2012
- Ribosomal Mutations as the Main Cause of Macrolide Resistance in Campylobacter jejuni and Campylobacter coliAntimicrobial Agents and Chemotherapy, 2011
- Genotype and Antibiotic Resistance Analyses of Campylobacter Isolates from Ceca and Carcasses of Slaughtered Broiler FlocksApplied and Environmental Microbiology, 2010
- Pork Contaminated with Salmonella enterica Serovar 4,[5],12:i:−, an Emerging Health Risk for HumansApplied and Environmental Microbiology, 2010
- Mutations in the rpsL Gene Are Involved in Streptomycin Resistance in Campylobacter coliMicrobial Drug Resistance, 2010
- Antibiotic Resistance in Campylobacter : Emergence, Transmission and PersistenceFuture Microbiology, 2009
- Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle*Journal of Applied Microbiology, 2006
- Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencingJournal of Applied Microbiology, 2004
- Evaluation of Sorivudine (BV‐araU) versus Acyclovir in the Treatment of Acute Localized Herpes Zoster in Human Immunodeficiency Virus‐Infected AdultsThe Journal of Infectious Diseases, 1997